These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 29444929)

  • 1. Development and External Validation of Prediction Models for 10-Year Survival of Invasive Breast Cancer. Comparison with PREDICT and CancerMath.
    Karapanagiotis S; Pharoah PDP; Jackson CH; Newcombe PJ
    Clin Cancer Res; 2018 May; 24(9):2110-2115. PubMed ID: 29444929
    [No Abstract]   [Full Text] [Related]  

  • 2. Validation of the online prediction model CancerMath in the Dutch breast cancer population.
    Hoveling LA; van Maaren MC; Hueting T; Strobbe LJA; Hendriks MP; Sonke GS; Siesling S
    Breast Cancer Res Treat; 2019 Dec; 178(3):665-681. PubMed ID: 31471837
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validation of the CancerMath prognostic tool for breast cancer in Southeast Asia.
    Miao H; Hartman M; Verkooijen HM; Taib NA; Wong HS; Subramaniam S; Yip CH; Tan EY; Chan P; Lee SC; Bhoo-Pathy N
    BMC Cancer; 2016 Oct; 16(1):820. PubMed ID: 27769212
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediction of lymph node involvement in patients with breast tumors measuring 3-5 cm in a middle-income setting: the role of CancerMath.
    Pijnappel EN; Bhoo-Pathy N; Suniza J; See MH; Tan GH; Yip CH; Hartman M; Taib NA; Verkooijen HM
    World J Surg; 2014 Dec; 38(12):3133-7. PubMed ID: 25167896
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Are we able to predict survival in ER-positive HER2-negative breast cancer? A comparison of web-based models.
    Laas E; Mallon P; Delomenie M; Gardeux V; Pierga JY; Cottu P; Lerebours F; Stevens D; Rouzier R; Reyal F
    Br J Cancer; 2015 Mar; 112(5):912-7. PubMed ID: 25590666
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Comparison Between the Online Prediction Models CancerMath and PREDICT as Prognostic Tools in Thai Breast Cancer Patients.
    Polchai N; Sa-Nguanraksa D; Numprasit W; Thumrongtaradol T; O-Charoenrat E; O-Charoenrat P
    Cancer Manag Res; 2020; 12():5549-5559. PubMed ID: 32753968
    [TBL] [Abstract][Full Text] [Related]  

  • 7. External validation and clinical utility assessment of PREDICT breast cancer prognostic model in young, systemic treatment-naïve women with node-negative breast cancer.
    Wang Y; Broeks A; Giardiello D; Hauptmann M; Jóźwiak K; Koop EA; Opdam M; Siesling S; Sonke GS; Stathonikos N; Ter Hoeve ND; van der Wall E; van Deurzen CHM; van Diest PJ; Voogd AC; Vreuls W; Linn SC; Dackus GMHE; Schmidt MK
    Eur J Cancer; 2023 Dec; 195():113401. PubMed ID: 37925965
    [TBL] [Abstract][Full Text] [Related]  

  • 8. How Does the Skeletal Oncology Research Group Algorithm's Prediction of 5-year Survival in Patients with Chondrosarcoma Perform on International Validation?
    Bongers MER; Karhade AV; Setola E; Gambarotti M; Groot OQ; Erdoğan KE; Picci P; Donati DM; Schwab JH; Palmerini E
    Clin Orthop Relat Res; 2020 Oct; 478(10):2300-2308. PubMed ID: 32433107
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does the SORG Algorithm Predict 5-year Survival in Patients with Chondrosarcoma? An External Validation.
    Bongers MER; Thio QCBS; Karhade AV; Stor ML; Raskin KA; Lozano Calderon SA; DeLaney TF; Ferrone ML; Schwab JH
    Clin Orthop Relat Res; 2019 Oct; 477(10):2296-2303. PubMed ID: 31107338
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An updated PREDICT breast cancer prognostication and treatment benefit prediction model with independent validation.
    Candido Dos Reis FJ; Wishart GC; Dicks EM; Greenberg D; Rashbass J; Schmidt MK; van den Broek AJ; Ellis IO; Green A; Rakha E; Maishman T; Eccles DM; Pharoah PDP
    Breast Cancer Res; 2017 May; 19(1):58. PubMed ID: 28532503
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical outcome and global gene expression data support the existence of the estrogen receptor-negative/progesterone receptor-positive invasive breast cancer phenotype.
    Schroth W; Winter S; Büttner F; Goletz S; Faißt S; Brinkmann F; Saladores P; Heidemann E; Ott G; Gerteis A; Alscher MD; Dippon J; Schwab M; Brauch H; Fritz P
    Breast Cancer Res Treat; 2016 Jan; 155(1):85-97. PubMed ID: 26650824
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene expression profiling for guiding adjuvant chemotherapy decisions in women with early breast cancer: an evidence-based and economic analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2010; 10(23):1-57. PubMed ID: 23074401
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PREDICT: a new UK prognostic model that predicts survival following surgery for invasive breast cancer.
    Wishart GC; Azzato EM; Greenberg DC; Rashbass J; Kearins O; Lawrence G; Caldas C; Pharoah PD
    Breast Cancer Res; 2010; 12(1):R1. PubMed ID: 20053270
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value of breast cancer subtypes, Ki-67 proliferation index, age, and pathologic tumor characteristics on breast cancer survival in Caucasian women.
    Ferguson NL; Bell J; Heidel R; Lee S; Vanmeter S; Duncan L; Munsey B; Panella T; Orucevic A
    Breast J; 2013; 19(1):22-30. PubMed ID: 23240985
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A simplified breast cancer prognostic score: comparison with the AJCC clinical prognostic staging system.
    Fei F; Zhang K; Siegal GP; Wei S
    Mod Pathol; 2021 Dec; 34(12):2141-2147. PubMed ID: 34365462
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A nomogram for determining the disease-specific survival in invasive lobular carcinoma of the breast: A population study.
    Fu R; Yang J; Wang H; Li L; Kang Y; Kaaya RE; Wang S; Lyu J
    Medicine (Baltimore); 2020 Oct; 99(43):e22807. PubMed ID: 33120801
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and validation of a new predictive model for breast cancer survival in New Zealand and comparison to the Nottingham prognostic index.
    Elwood JM; Tawfiq E; TinTin S; Marshall RJ; Phung TM; Campbell I; Harvey V; Lawrenson R
    BMC Cancer; 2018 Sep; 18(1):897. PubMed ID: 30223800
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The prognostic relevance of FOXA1 and Nestin expression in breast cancer metastases: a retrospective study of 164 cases during a 10-year period (2004-2014).
    De Lara S; Nyqvist J; Werner Rönnerman E; Helou K; Kenne Sarenmalm E; Einbeigi Z; Karlsson P; Parris TZ; Kovács A
    BMC Cancer; 2019 Feb; 19(1):187. PubMed ID: 30819139
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Independent validation of the PREDICT breast cancer prognosis prediction tool in 45,789 patients using Scottish Cancer Registry data.
    Gray E; Marti J; Brewster DH; Wyatt JC; Hall PS;
    Br J Cancer; 2018 Oct; 119(7):808-814. PubMed ID: 30220705
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Poor prognosis of single hormone receptor- positive breast cancer: similar outcome as triple-negative breast cancer.
    Bae SY; Kim S; Lee JH; Lee HC; Lee SK; Kil WH; Kim SW; Lee JE; Nam SJ
    BMC Cancer; 2015 Mar; 15():138. PubMed ID: 25880075
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.